Hanna S. Radomska

This researcher's recent work focuses on designing and testing small molecules that target hormone receptors, particularly estrogen receptor beta and androgen receptor, for potential treatment of cancers such as breast, liver, and prostate-related conditions. Earlier work also touched on gene regulation involving RNA molecules and transcription factors linked to blood cell development. The research combines chemical synthesis of new drug candidates with laboratory testing of their biological effects.

Publication output was minimal or absent from 2017-2019, spiked in 2020, dipped briefly, then has grown steadily from 2022 through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026